Abstract |
In a multicenter study, 61 patients, 18-70 years of age, with mild-to-moderate hypertension [diastolic blood pressure (DBP) 95/114] completed a 28-week treatment. After initial placebo washout, patients were randomly allocated either to diltiazem or hydrochlorothiazide/triamterene. At the end of 12 weeks, the patients continued on the same medication if their goal blood pressure achieved (DBP less than 90; or 10 mm Hg below baseline). If not, the alternate agent was added (either diltiazem + hydrochlorothiazide/triamterene or hydrochlorothiazide/triamterene + diltiazem). At the end of 28 weeks, the intent-to-treat analysis showed that 90% on diltiazem alone, 73.7% on hydrochlorothiazide/triamterene alone, 71.4% on ( diltiazem + hydrochlorothiazide/triamterene), and 57.1% on ( hydrochlorothiazide/triamterene + diltiazem) achieved goal BP. End point mean values of BP and heart rate after adjusting for sex, baseline values, age, and weight showed no significant difference between groups. Forty-six percent on hydrochlorothiazide/triamterene alone and 24% on diltiazem alone reported one or more adverse events, possibly related to study medication. Patients with diltiazem as the first choice had better BP control than those on hydrochlorothiazide/triamterene alone (81.5% vs. 69.7%). Furthermore, among non-goal achievers at week 12, there was a greater response in the group when hydrochlorothiazide/triamterene was added to diltiazem than when diltiazem was added to hydrochlorothiazide/triamterene. This study suggests that in mild-to-moderate hypertension, diltiazem is better than hydrochlorothiazide/triamterene as first line therapy.
|
Authors | A P Boulet, A Chockalingam, J G Fodor, L Laplante, M Houde, J Lenis, A G Logan, M N Robitaille, D Ryan, J Spénard |
Journal | Journal of cardiovascular pharmacology
(J Cardiovasc Pharmacol)
Vol. 18 Suppl 9
Pg. S45-50
( 1991)
ISSN: 0160-2446 [Print] United States |
PMID | 1725543
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Calcium Channel Blockers
- Diuretics
- Hydrochlorothiazide
- Diltiazem
- Potassium
- Triamterene
|
Topics |
- Adolescent
- Adult
- Aged
- Calcium Channel Blockers
(therapeutic use)
- Diltiazem
(adverse effects, therapeutic use)
- Diuretics
(therapeutic use)
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Humans
- Hydrochlorothiazide
(adverse effects, therapeutic use)
- Hypertension
(drug therapy)
- Male
- Middle Aged
- Potassium
(metabolism)
- Single-Blind Method
- Time Factors
- Triamterene
(adverse effects, therapeutic use)
|